fremtidbio.

A NEW FRONTIER IN ANTIMICROBIAL DISCOVERY

New molecules.
A different
future.

We connect AI, bioinformatics and experimental science to discover the next generation of antimicrobial drugs.

Explore our approach

Resistance evolves.
So must discovery.

Antimicrobial resistance challenges our ability to treat infections. New ways to discover effective drugs are urgently needed.

We explore two complementary paths: antimicrobial peptides and small molecules. Each connects biological insight with computational design and experimental testing.

Where we focus

Intelligence meets
experimental evidence.

A connected cycle of insight, design and testing.
Each result informs what comes next.

01 / BIOINFORMATICS

Find the signals that matter.

Explore biological data to understand pathogens, resistance mechanisms and opportunities for intervention. Translate complex information into focused discovery questions.

Biological insightTarget prioritisationResistance context
Published research, genomic data and cells connected to reveal biological insights

Two molecular paths.
One shared purpose.

Exploring different molecular possibilities
to address antimicrobial resistance.

MODALITY 01PEPTIDES
Conceptual lavender peptide helix with molecular side chains

Antimicrobial peptides

Exploring the potential of peptide sequences to act against microbes. Our discovery approach connects sequence design with experimental assessment of activity and selectivity.

Explore a collaboration
MODALITY 02SMALL MOLECULES
Conceptual small-molecule model in sage green and violet

Small-molecule drugs

Exploring chemical space for new antimicrobial starting points. Biological insight, AI-guided design and parallel testing help focus the search for promising compounds.

Explore a collaboration
View our development pipeline Selected candidates. Next steps.

Our focus is drug discovery. Research candidates are not approved medicines.

The people behind
the possibilities.

Our story and team

The next discovery
starts with a
conversation.

We welcome conversations with research teams, biotechnology companies and partners who share our ambition to advance antimicrobial discovery.

Let’s talk
Research collaborationsDiscovery partnershipsStrategic conversations